FDA’s CDER Pharmacology Toxicology Symposium

On May 13, 2024, several esteemed members from HESI’s Genetic Toxicology Technical Committee (GTTC) and Emerging Systems Toxicology for the Assessment of Risk Committee (eSTAR) delivered insightful presentations at the FDA's CDER Pharmacology Toxicology Symposium. This event, organized by the Education Subcommittee, focused on "Error-Corrected Next Generation Sequencing Strategies for Direct Assessment of Mutagenesis and Early Identification of Cancer Risk."

Originally presented at the 2024 Society of Toxicology Annual Meeting, this session was co-chaired by Connie Chen (HESI) and Stephanie Smith-Roe (DTT/NIEHS). The impressive lineup of speakers included Sheroy Minocherhomji (Lilly), Jesse Salk (University of Washington), Anthony Lynch (GSK), Francesco Marchetti (Health Canada), Carole Yauk (University of Ottawa), and Arun Pandiri (DTT/NIEHS).

The education webinar attracted over 160 attendees from various FDA centers, reflecting the high level of interest and engagement in these cutting-edge topics.